Company registration number 10947751 (England and Wales)
SOUTH WEST MEDICAL & SURGICAL LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
SOUTH WEST MEDICAL & SURGICAL LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
SOUTH WEST MEDICAL & SURGICAL LTD
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
36,057
37,716
Current assets
Debtors
4
7,453
4,518
Cash at bank and in hand
1,923
564
9,376
5,082
Creditors: amounts falling due within one year
5
(40,170)
(50,884)
Net current liabilities
(30,794)
(45,802)
Net assets/(liabilities)
5,263
(8,086)
Capital and reserves
Called up share capital
20
20
Profit and loss reserves
5,243
(8,106)
Total equity
5,263
(8,086)

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 8 February 2026 and are signed on its behalf by:
Dr R S Tingay
Director
Company registration number 10947751 (England and Wales)
SOUTH WEST MEDICAL & SURGICAL LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 2 -
1
Accounting policies
Company information

South West Medical & Surgical Ltd is a private company limited by shares incorporated in England and Wales. The registered office is The Summit, Woodwater Park, Pynes Hill, Exeter, EX2 5WS.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
20% per annum on net book value
Motor vehicles
20% per annum on net book value

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

SOUTH WEST MEDICAL & SURGICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 3 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
SOUTH WEST MEDICAL & SURGICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 4 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 October 2024
40,710
Additions
5,994
At 30 September 2025
46,704
Depreciation and impairment
At 1 October 2024
2,994
Depreciation charged in the year
7,653
At 30 September 2025
10,647
Carrying amount
At 30 September 2025
36,057
At 30 September 2024
37,716
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
3,856
1,441
Other debtors
2,771
1,611
6,627
3,052
Deferred tax asset
826
1,466
7,453
4,518
5
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
2,491
-
0
Other creditors
36,279
49,614
Accruals and deferred income
1,400
1,270
40,170
50,884
2025-09-30 2024-10-01 false false false 11 February 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr R S Tingay Dr E J Elsey 10947751 2024-10-01 2025-09-30 10947751 2025-09-30 10947751 2024-09-30 10947751 core:OtherPropertyPlantEquipment 2025-09-30 10947751 core:OtherPropertyPlantEquipment 2024-09-30 10947751 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 10947751 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 10947751 core:CurrentFinancialInstruments 2025-09-30 10947751 core:CurrentFinancialInstruments 2024-09-30 10947751 core:ShareCapital 2025-09-30 10947751 core:ShareCapital 2024-09-30 10947751 core:RetainedEarningsAccumulatedLosses 2025-09-30 10947751 core:RetainedEarningsAccumulatedLosses 2024-09-30 10947751 bus:Director1 2024-10-01 2025-09-30 10947751 core:FurnitureFittings 2024-10-01 2025-09-30 10947751 core:MotorVehicles 2024-10-01 2025-09-30 10947751 2023-10-01 2024-09-30 10947751 core:OtherPropertyPlantEquipment 2024-09-30 10947751 core:OtherPropertyPlantEquipment 2024-10-01 2025-09-30 10947751 core:WithinOneYear 2025-09-30 10947751 core:WithinOneYear 2024-09-30 10947751 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 10947751 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 10947751 bus:FRS102 2024-10-01 2025-09-30 10947751 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 10947751 bus:Director2 2024-10-01 2025-09-30 10947751 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP